171 related articles for article (PubMed ID: 21698775)
1. Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation.
Maga G; Falchi F; Radi M; Botta L; Casaluce G; Bernardini M; Irannejad H; Manetti F; Garbelli A; Samuele A; Zanoli S; Esté JA; Gonzalez E; Zucca E; Paolucci S; Baldanti F; De Rijck J; Debyser Z; Botta M
ChemMedChem; 2011 Aug; 6(8):1371-89. PubMed ID: 21698775
[TBL] [Abstract][Full Text] [Related]
2. Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors.
Radi M; Falchi F; Garbelli A; Samuele A; Bernardo V; Paolucci S; Baldanti F; Schenone S; Manetti F; Maga G; Botta M
Bioorg Med Chem Lett; 2012 Mar; 22(5):2094-8. PubMed ID: 22300661
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3.
Maga G; Falchi F; Garbelli A; Belfiore A; Witvrouw M; Manetti F; Botta M
J Med Chem; 2008 Nov; 51(21):6635-8. PubMed ID: 18834110
[TBL] [Abstract][Full Text] [Related]
4. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
[TBL] [Abstract][Full Text] [Related]
6. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
[TBL] [Abstract][Full Text] [Related]
8. Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors.
Fazi R; Tintori C; Brai A; Botta L; Selvaraj M; Garbelli A; Maga G; Botta M
J Chem Inf Model; 2015 Nov; 55(11):2443-54. PubMed ID: 26544088
[TBL] [Abstract][Full Text] [Related]
9. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
11. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation.
Schröder M
Biochem Pharmacol; 2010 Feb; 79(3):297-306. PubMed ID: 19782656
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.
Fattorusso C; Gemma S; Butini S; Huleatt P; Catalanotti B; Persico M; De Angelis M; Fiorini I; Nacci V; Ramunno A; Rodriquez M; Greco G; Novellino E; Bergamini A; Marini S; Coletta M; Maga G; Spadari S; Campiani G
J Med Chem; 2005 Nov; 48(23):7153-65. PubMed ID: 16279773
[TBL] [Abstract][Full Text] [Related]
13. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.
Brai A; Fazi R; Tintori C; Zamperini C; Bugli F; Sanguinetti M; Stigliano E; Esté J; Badia R; Franco S; Martinez MA; Martinez JP; Meyerhans A; Saladini F; Zazzi M; Garbelli A; Maga G; Botta M
Proc Natl Acad Sci U S A; 2016 May; 113(19):5388-93. PubMed ID: 27118832
[TBL] [Abstract][Full Text] [Related]
14. DDX3 RNA helicase is required for HIV-1 Tat function.
Yasuda-Inoue M; Kuroki M; Ariumi Y
Biochem Biophys Res Commun; 2013 Nov; 441(3):607-11. PubMed ID: 24183723
[TBL] [Abstract][Full Text] [Related]
15. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
16. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
17. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
[TBL] [Abstract][Full Text] [Related]
19. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.
Yedavalli VS; Neuveut C; Chi YH; Kleiman L; Jeang KT
Cell; 2004 Oct; 119(3):381-92. PubMed ID: 15507209
[TBL] [Abstract][Full Text] [Related]
20. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]